Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Adam Brownhill"'
Autor:
Matthew I. Balcerek, Brendan J. Nolan, Adam Brownhill, Peggy Wong, Peter Locke, Jeffrey D. Zajac, Ada S. Cheung
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
ContextThe safety and efficacy of feminizing hormone therapy in aging transgender (trans) individuals is unclear. Current recommendations suggest transdermal estradiol beyond the age of 45 years, especially if cardiometabolic risk factors are present
Externí odkaz:
https://doaj.org/article/4fcd07a355d04bc981d4cd08db1cd2e1
Autor:
Brendan J. Nolan, Adam Brownhill, Ingrid Bretherton, Peggy Wong, Susan Fox, Peter Locke, Nicholas Russell, Mathis Grossmann, Jeffrey D. Zajac, Ada S. Cheung
Publikováno v:
Therapeutic Advances in Endocrinology and Metabolism, Vol 11 (2020)
Aim: Feminising hormone therapy with estradiol is used to align an individual’s physical characteristics with their gender identity. Given considerable variations in doses of estradiol therapy administered as gender-affirming hormone therapy (GAHT)
Externí odkaz:
https://doaj.org/article/104440ef885744b6a09969b6042e0848
Autor:
Ada S Cheung, Adam Brownhill, Peggy Wong, Jeffrey D Zajac, Pauline Cundill, Shalem Leemaqz, Cassandra Spanos, Julian A. Grace, Peter Locke
Publikováno v:
The Journal of Sexual Medicine. 18:201-208
BACKGROUND: There are 2 common approaches to assess an individual before commencing of gender-affirming hormone therapy (GAHT); a mental health practitioner assessment and approval or an informed consent model undertaken with a primary care general p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9247de8b5ae4f71d950c83ee1587d2bd
https://doi.org/10.1016/j.jsxm.2020.10.020
https://doi.org/10.1016/j.jsxm.2020.10.020
Autor:
Peter Locke, Nicholas D. F. Russell, Mathis Grossmann, Jeffrey D Zajac, Brendan J Nolan, Adam Brownhill, Ingrid Bretherton, Peggy Wong, Susan Fox, Ada S Cheung
Publikováno v:
Journal of the Endocrine Society
Background: Feminizing hormone therapy with estradiol is used to align an individual’s physical characteristics with their gender identity. Australian expert consensus guidelines (1) recommend targeting estradiol concentrations of 250-600 pmol/L (6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcc4582d6f290a302feaf4de88beae73
http://europepmc.org/articles/PMC7208259
http://europepmc.org/articles/PMC7208259
Autor:
Ada S Cheung, Peggy Wong, Jeffrey D Zajac, Peter Locke, Susan Fox, Nicholas Russell, Brendan J Nolan, Adam Brownhill, Mathis Grossmann, Ingrid Bretherton
Publikováno v:
Therapeutic Advances in Endocrinology and Metabolism, Vol 11 (2020)
Therapeutic Advances in Endocrinology and Metabolism
Therapeutic Advances in Endocrinology and Metabolism
Aim: Feminising hormone therapy with estradiol is used to align an individual’s physical characteristics with their gender identity. Given considerable variations in doses of estradiol therapy administered as gender-affirming hormone therapy (GAHT)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fa01159c9ec61d00985f39f781fe9d5
https://doi.org/10.1177/2042018820924543
https://doi.org/10.1177/2042018820924543